Trial
NCT05101447
Pharmacokinetically-driven Dosing of Mycophenolate Mofetil for the Treatment of Pediatric Proliferative Lupus Nephritis
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Children's Hospital Medical Center, Cincinnati
Collaborators
—
Condition
Lupus Nephritis
Intervention
Mycophenolate Mofetil
Why stopped
funding not secured
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-08-30